Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
appeal, attorney, certificate, charge, exceeded, expedite, extension, extinguishment, Fast, heard, mixed, nonrecurring, paragraph, preceding, range, receding, redemption, site, size, testing, threatening, unmet
Removed:
achieved, assumed, dispute, evaluable, involving
Filing tables
Filing exhibits
Related press release
GALT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-116629, 333-109893, 333-159247, 333-176306 and 333-176305 on Form S-8, and Registration Nos. 333-169463, 333-172849 and 333-148911 on Form S-3, of our report dated March 29, 2013 relating to our audit of the consolidated financial statements, which appear in the Annual Report on Form 10-K of Galectin Therapeutics Inc. for the year ended December 31, 2012.
/s/ McGladrey LLP
Boston, Massachusetts
August 14, 2013